ATE361743T1 - Beschichtete minitabletten von venlafaxinhydrochlorid mit verlängerter freisetzung - Google Patents

Beschichtete minitabletten von venlafaxinhydrochlorid mit verlängerter freisetzung

Info

Publication number
ATE361743T1
ATE361743T1 AT04821278T AT04821278T ATE361743T1 AT E361743 T1 ATE361743 T1 AT E361743T1 AT 04821278 T AT04821278 T AT 04821278T AT 04821278 T AT04821278 T AT 04821278T AT E361743 T1 ATE361743 T1 AT E361743T1
Authority
AT
Austria
Prior art keywords
extended
venlafaxine hydrochloride
release coated
mini tablets
coated mini
Prior art date
Application number
AT04821278T
Other languages
English (en)
Inventor
Sampad Bhattacharya
Rajesh Kshirsagar
Mayank Joshi
Sandeep Pandita
Original Assignee
Alembic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alembic Ltd filed Critical Alembic Ltd
Application granted granted Critical
Publication of ATE361743T1 publication Critical patent/ATE361743T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT04821278T 2004-02-04 2004-10-27 Beschichtete minitabletten von venlafaxinhydrochlorid mit verlängerter freisetzung ATE361743T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN117MU2004 2004-02-04
IN980MU2004 2004-09-13

Publications (1)

Publication Number Publication Date
ATE361743T1 true ATE361743T1 (de) 2007-06-15

Family

ID=34809925

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04821278T ATE361743T1 (de) 2004-02-04 2004-10-27 Beschichtete minitabletten von venlafaxinhydrochlorid mit verlängerter freisetzung

Country Status (24)

Country Link
US (1) US7807195B2 (de)
EP (1) EP1711169B1 (de)
JP (1) JP2007520547A (de)
KR (1) KR20070000439A (de)
AT (1) ATE361743T1 (de)
AU (1) AU2004315136B2 (de)
BR (1) BRPI0418283A (de)
CA (1) CA2555295C (de)
CY (1) CY1106741T1 (de)
DE (1) DE602004006443T2 (de)
DK (1) DK1711169T3 (de)
ES (1) ES2287813T3 (de)
HK (1) HK1091137A1 (de)
HR (1) HRP20070353T3 (de)
IL (1) IL177243A0 (de)
MX (1) MXPA06008854A (de)
NO (1) NO20063809L (de)
NZ (1) NZ548504A (de)
PL (1) PL1711169T3 (de)
PT (1) PT1711169E (de)
RU (1) RU2340331C2 (de)
SI (1) SI1711169T1 (de)
UA (1) UA82597C2 (de)
WO (1) WO2005074895A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL146462A (en) 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
PL377473A1 (pl) * 2002-11-28 2006-02-06 Themis Laboratories Private Limited Sposób produkcji mikropeletek o przedłużonym uwalnianiu zawierających chlorowodorek wenlafaksyny
WO2006136927A1 (en) * 2005-06-22 2006-12-28 Glenmark Pharmaceuticals Limited Extended release formulations comprising venlafaxine
EP1906935A4 (de) * 2005-07-28 2010-10-20 Reddys Lab Ltd Dr Venlafaxin-zusammensetzungen mit verlängerter freisetzung
WO2007102169A1 (en) * 2006-03-08 2007-09-13 Jubilant Organosys Limited Extended release pharmaceutical formulation of venlafaxine and method of manufacturing the same
CA2648278C (en) * 2006-04-03 2019-05-28 Isa Odidi Drug delivery composition
WO2007112574A1 (en) * 2006-04-03 2007-10-11 Isa Odidi Extended release composition of venlafaxine
WO2007129329A2 (en) * 2006-05-08 2007-11-15 Jubilant Organosys Limited Extended release pharmaceutical formulation comprising venlafaxine hydrochloride
JP2010513328A (ja) * 2006-12-20 2010-04-30 ミラン ファーマシューティカルズ ユーエルシー ビタミンｄおよびビスホスホン酸を含有する組成物
JP5290198B2 (ja) * 2006-12-20 2013-09-18 ミラン ファーマシューティカルズ ユーエルシー ホットメルト顆粒化潤滑剤を含んでなる医薬組成物
TWI391150B (zh) * 2008-01-22 2013-04-01 Taiwan Biotech Co Ltd 腸溶性長效塗覆芯與藥物劑型及其製造方法
CN101756934A (zh) * 2008-12-10 2010-06-30 上海复星普适医药科技有限公司 文拉法辛缓释制剂的制备方法
KR101787481B1 (ko) 2010-10-21 2017-10-18 롯데정밀화학 주식회사 장용성 경질 캡슐용 조성물 및 상기 조성물을 사용하여 제조된 장용성 경질 캡슐
EP2670409B1 (de) 2011-01-31 2018-04-18 Serotech, LLC Dosierungsplan, medikamentenausgabeverpackung und ihre verwendung zur behandlung von schweren depressionen
DK3395342T3 (da) 2015-12-25 2020-10-12 Fujifilm Toyama Chemical Co Ltd Tablet omfattende 1-(3-(2-(1-benzothiophen-5-YL)ethoxy)propyl)azetidin-3-ol eller salt deraf
KR102062052B1 (ko) * 2018-03-20 2020-01-03 일양약품주식회사 베타네콜 서방성 제제 및 이의 제조방법
KR20230067863A (ko) 2021-11-10 2023-05-17 박찬호 스마트 계량도구 및 이를 이용한 요리보조 시스템

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4153677A (en) * 1978-05-18 1979-05-08 Sterling Drug Inc. Controlled-release composition
US4535186A (en) 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6274171B1 (en) * 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
PE57198A1 (es) 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
UA77145C2 (en) 1997-11-05 2006-11-15 Wyeth Corp Extended release dosage formulation
AU768277B2 (en) * 1998-05-15 2003-12-04 Warner-Lambert Company Llc Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
JP2003514847A (ja) 1999-11-22 2003-04-22 アルザ・コーポレーション 第一コートおよび第二コートを含む浸透圧性剤形
US6346269B1 (en) * 2000-05-08 2002-02-12 Standard Chem. & Pharm. Co., Ltd. Method for preparing an oral formulation containing acid-sensitive drugs and oral formulation made thereby
US6350471B1 (en) * 2000-05-31 2002-02-26 Pharma Pass Llc Tablet comprising a delayed release coating
MXPA03009588A (es) * 2001-04-18 2004-12-06 Nostrum Pharmaceuticals Inc Un recubrimiento novedoso para una composicion farmaceutica de liberacion sostenida.
US20030091634A1 (en) * 2001-09-14 2003-05-15 Pawan Seth Delayed release tablet of venlafaxin
EP1455751A1 (de) 2001-12-20 2004-09-15 Pharmacia Corporation Retardarzneiformen mit wirkstofffreisetzung nullter ordnung und deren herstellungsmethoden
WO2003055475A1 (en) * 2002-01-03 2003-07-10 Lek Pharmaceutical And Chemical Company D.D. Controlled release pharmaceutical formulation containing venlafaxine
WO2003082805A1 (en) * 2002-03-28 2003-10-09 Synthon B.V. Low water-soluble venlafaxine salts
AU2003226752A1 (en) * 2002-03-28 2003-10-13 Synthon B.V. Venlafaxine base
IL149055A0 (en) * 2002-04-09 2002-11-10 Karma Pharm Ltd Extended release composition comprising as active compound venlafaxine hydrochloride
BR0312445A (pt) * 2002-06-07 2005-05-10 Ranbaxy Lab Ltd Sistemas multiunitários para disponibilização de fármaco de liberação modificada
US8216609B2 (en) 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
US7058999B2 (en) * 2002-10-24 2006-06-13 Paramount Bed Co., Ltd. Electric bed and control apparatus and control method therefor
CA2503380A1 (en) * 2002-10-25 2004-05-06 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions containing venlafaxine
US6703044B1 (en) * 2002-10-25 2004-03-09 Dexcel Pharma Tech, Ltd Venlafaxine formulations
US20060246132A1 (en) * 2003-02-07 2006-11-02 Fjalar Johannsson Sustained release formulations of venlafaxine
SI1502587T1 (sl) * 2003-07-30 2007-02-28 Pharmathen Sa Formulacija z zadrzevanim sproscanjem za Venlafaxin hidroklorid
US7016014B2 (en) * 2004-02-27 2006-03-21 Asml Netherlands B.V Lithographic apparatus and device manufacturing method

Also Published As

Publication number Publication date
EP1711169B1 (de) 2007-05-09
NO20063809L (no) 2006-08-25
DE602004006443D1 (de) 2007-06-21
MXPA06008854A (es) 2007-01-23
US7807195B2 (en) 2010-10-05
BRPI0418283A (pt) 2007-05-02
IL177243A0 (en) 2006-12-10
DE602004006443T2 (de) 2008-01-10
KR20070000439A (ko) 2007-01-02
EP1711169A1 (de) 2006-10-18
AU2004315136A1 (en) 2005-08-18
PL1711169T3 (pl) 2007-10-31
JP2007520547A (ja) 2007-07-26
HK1091137A1 (en) 2007-01-12
PT1711169E (pt) 2007-07-23
NZ548504A (en) 2009-03-31
ES2287813T3 (es) 2007-12-16
US20050169985A1 (en) 2005-08-04
DK1711169T3 (da) 2007-09-17
HRP20070353T3 (en) 2008-01-31
RU2006129034A (ru) 2008-03-10
AU2004315136B2 (en) 2010-06-17
CA2555295C (en) 2011-01-18
SI1711169T1 (sl) 2007-10-31
CY1106741T1 (el) 2012-05-23
CA2555295A1 (en) 2005-08-18
WO2005074895A1 (en) 2005-08-18
UA82597C2 (uk) 2008-04-25
RU2340331C2 (ru) 2008-12-10

Similar Documents

Publication Publication Date Title
HK1091137A1 (en) Extended release coated minitablets of venlafaxinehydrochloride
WO2008027557A3 (en) Topiramate compositions and methods of enhancing its bioavailability
RS52169B (en) STABLE LAKVINIMOD PREPARATIONS
AP2012006231A0 (en) Capsule formulation of pirfenidone and pharmaceutically acceptable excipients.
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
ATE454138T1 (de) Tablette mit modifizierter freisetzung von bupropion hydrochlorid
EA200970267A1 (ru) ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ВКЛЮЧАЮЩАЯ МНОЖЕСТВО МИНИ-ТАБЛЕТОК, СОДЕРЖАЩИХ ИНГИБИТОР ФАКТОРА Xa
CR8102A (es) Derivados de pirazolo- quinazolina, procedimiento para preparacion y su uso como inhibidores de quinasa
TW200616640A (en) Novel pharmaceutical formulations of active principles
EA200801926A1 (ru) Таблетки парацетамола с быстрым высвобождением
SG152257A1 (en) Topical preparation containing ambroxol
HK1089950A1 (en) Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form
JO2973B1 (en) Fumarate salt for (alpha-beta-R) -6-bromo-alpha-[2- (methylamino) ethyl-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinoline ethanol
TW200738228A (en) Neramexane modified release matrix tablet
NO20081038L (no) Farmasoytiske formuleringer/sammensetninger av guanfacin egnet for daglig enkel doseform administrering
BRPI0513598A (pt) formas de dosagem em comprimidos revestidos de liberação entérica
AR066924A1 (es) Formulacion de nevirapina de liberacion prolongada
MXPA03010054A (es) Composiciones que comprenden lopinavir y metodos para aumentar la biodisponibilidad de agentes farmaceuticos.
WO2005107709A3 (en) Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients
ITMI20050387A1 (it) Nuove capsule di gelatina molle
CO6351711A2 (es) Combinacion de dosis fija en la forma de una tableta de dos copas o de una sola capa de alisquireno y amlodipina
TNSN06242A1 (en) Extended release coated minitablets of venlafaxine hydrochloride
TW200716114A (en) Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof
ATE357220T1 (de) Pharmazeutische zusammensetzung mit modifizierter freisetzung
ATE402703T1 (de) Tablette enthaltend efletirizin und pseudoephedrin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1711169

Country of ref document: EP

REN Ceased due to non-payment of the annual fee